The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125238221 12523822 1 I 20160510 20160620 20160704 20160704 EXP FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-052084 BRISTOL MYERS SQUIBB 73.43 YR F Y 0.00000 20160704 OT FR FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125238221 12523822 1 PS METFORMIN HYDROCHLORIDE. METFORMIN HYDROCHLORIDE 1 Oral 1 DF, UNK U 20357 1 DF FILM-COATED TABLET
125238221 12523822 2 SS LERCANIDIPINE LERCANIDIPINE 1 Oral 1 DF, UNK U 0 1 DF
125238221 12523822 3 SS TELMISARTAN. TELMISARTAN 1 Oral 1 DF, UNK U 0 1 DF
125238221 12523822 4 SS REPAGLINIDE. REPAGLINIDE 1 Oral 4 MG, UNK U 0 4 MG
125238221 12523822 5 SS DESLORATADIN DESLORATADINE 1 Oral 1 DF, UNK U 0 1 DF
125238221 12523822 6 SS XELEVIA SITAGLIPTIN PHOSPHATE 1 Oral 1 DF, UNK U 0 1 DF
125238221 12523822 7 SS CRESTOR ROSUVASTATIN CALCIUM 1 Oral 1 DF, UNK U 0 1 DF
125238221 12523822 8 C NAPROXEN. NAPROXEN 1 Unknown UNK U 0
125238221 12523822 9 C PANTOPRAZOLE PANTOPRAZOLE SODIUM 1 Unknown UNK U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125238221 12523822 1 Diabetes mellitus
125238221 12523822 2 Hypertension
125238221 12523822 3 Hypertension
125238221 12523822 4 Diabetes mellitus
125238221 12523822 5 Product used for unknown indication
125238221 12523822 6 Diabetes mellitus
125238221 12523822 7 Dyslipidaemia
125238221 12523822 8 Product used for unknown indication
125238221 12523822 9 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
125238221 12523822 HO
125238221 12523822 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125238221 12523822 Alanine aminotransferase increased
125238221 12523822 Aspartate aminotransferase increased
125238221 12523822 Cough
125238221 12523822 Eosinophilia
125238221 12523822 Feeling cold
125238221 12523822 Gamma-glutamyltransferase increased
125238221 12523822 Hypoxia
125238221 12523822 Liver injury
125238221 12523822 Myalgia
125238221 12523822 Pleural effusion
125238221 12523822 Pulmonary mass
125238221 12523822 Pyrexia
125238221 12523822 Rash
125238221 12523822 Rash maculo-papular
125238221 12523822 Toxic skin eruption

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125238221 12523822 1 20160518 0
125238221 12523822 2 20160518 0
125238221 12523822 3 20160518 20160518 0
125238221 12523822 4 20160518 0
125238221 12523822 5 20160518 0
125238221 12523822 6 20160518 0
125238221 12523822 7 20160518 0
125238221 12523822 8 20160411 20160418 0
125238221 12523822 9 20160411 20160418 0